1,666 followers
RT @FrontOncology: 📣 Opinion Article - Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lym…
RT @FrontOncology: 📣 Opinion Article - Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lym…